Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab. Article uri icon

Overview

publication date

  • June 12, 2023

Research

keywords

  • Antibodies, Bispecific
  • Antineoplastic Agents
  • Lymphoma, Non-Hodgkin
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma

Identity

PubMed Central ID

  • PMC10773239

Scopus Document Identifier

  • 85161815845

Digital Object Identifier (DOI)

  • 10.1080/10428194.2023.2221756

PubMed ID

  • 37309201

Additional Document Info

volume

  • 64

issue

  • 9